| 1 |
35217309 | Combining selinexor with alisertib to target the p53 pathway in neuroblastoma. | 2022 Apr |
1 |
| 2 |
30177840 | TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells. | 2019 Feb |
1 |
| 3 |
30755439 | Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck. | 2019 Jun 1 |
1 |
| 4 |
31063779 | Analysis of Liver Cancer Cell Lines Identifies Agents With Likely Efficacy Against Hepatocellular Carcinoma and Markers of Response. | 2019 Sep |
1 |
| 5 |
31647033 | Inhibition of Aurora A enhances radiosensitivity in selected lung cancer cell lines. | 2019 Oct 23 |
2 |
| 6 |
25366143 | Alisertib (MLN8237), a selective Aurora-A kinase inhibitor, induces apoptosis in human tongue squamous cell carcinoma cell both in vitro and in vivo. | 2015 Mar |
1 |
| 7 |
25758253 | p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer. | 2015 May |
3 |
| 8 |
24240108 | HDM2 regulation by AURKA promotes cell survival in gastric cancer. | 2014 Jan 1 |
1 |